Skip to main content
. 2024 Jan 20;24:119. doi: 10.1186/s12903-024-03891-w

Table 2.

The BMP-2, FGF-2, VEGF, and ALP levels of each group on days 1, 3 and 7. BMP-2 levels significantly increased over time in all CSC groups, contrasting with the control group where they remained consistent. The highest FGF-2 levels were seen in Biodentine and NeoMTA groups on day 7. Bio MTA+ and NeoMTA exposure had no significant impact on VEGF levels at any time point, with the maximum VEGF level observed in the Biodentine group on day 7. All CSCs demonstrated elevated ALP activity compared to the control on days 3 and 7, with the highest ALP activity observed in the Biodentine and NeoMTA groups on day 7

Markers Day Groups
Bio MTA+ Biodentine MTA CEM NeoMTA Control Test statistics*
BMP-2 Day 1 180.1 ± 21.1ab 168.8 ± 31.9ab 132.4 ± 4.1a 147.4 ± 16.9a 90.3 ± 4.5a 6125.968
Day 3 1142,5 ± 101.9c 1055.3 ± 46.1c 861.6 ± 112.1c 898.5 ± 58c 103 ± 7.4a
Day 7 2620.2 ± 320.1d 2438.3 ± 215.7df 1954.8 ± 118.8h 2295.6 ± 241.5f 156 ± 8.6a
FGF-2 Day 1 35.8 ± 1.6a 38.5 ± 4.3aef 36.3 ± 3.9ae 33.8 ± 2.2a 31.3 ± 1.4a 2783.987
Day 3 71 ± 13.7bc 77.7 ± 5.1b 54.8 ± 0.9cfgi 53.4 ± 0.9efgi 34 ± 1.9a
Day 7 119.5 ± 23.6d 147.4 ± 8.2h 68 ± 5.3bci 138.6 ± 16h 37 ± 1.5ae
VEGF Day 1 88.3 ± 16.6abc 117 ± 10.8abcd 96 ± 3.5abc 75.4 ± 1.7bc 61.9 ± 6.3c 4108.873
Day 3 118.6 ± 6.6abcd 251.6 ± 27.3f 172.3 ± 9.5adef 115.9 ± 14.9abcd 79.1 ± 3.6bc
Day 7 152.4 ± 10.6abde 1050.9 ± 147.6g 363 ± 56.7h 88.8 ± 46.9abc 92.7 ± 2.2abc
ALP Day 1 175.8 ± 4.4abcde 261.3 ± 26.8fhij 121.2 ± 16.2blnoprst 144.3 ± 21.6bcdlmnoprs 82.1 ± 1.9t 1867.538
Day 3 237.4 ± 16.8fghijk 293.6 ± 22h 247.1 ± 28.4efhijk 183 ± 17.2acdegkm 87.6 ± 1.8ost
Day 7 263.9 ± 23.4fhj 380.1 ± 22.9q 265.8 ± 10.7hj 382.9 ± 35.1q 91.7 ± 1.3norst

*Wald Chi-Squared Test; Degree of freedom (df) = 29, a-i: For each marker, different letters represent significant differences between groups (p < 001)